Fujifilm : to Reorganize its Medical Systems Group Companies in Japan (Fujifilm)

Under its medium-term management plan "VISION2023," Fujifilm is accelerating business growth in healthcare, identifying it as one of its key business fields. In the Medical Systems business, a growth driver in healthcare, the company provides high-quality diagnostic solutions globally by placing medical IT at the core and connecting its extensive product lines, including X-ray diagnostic imaging systems and endoscopes based on the SYNAPSE medical imaging information systems, which boasts the world's top market share. In March 2021, Fujifilm acquired the Diagnostic Imaging-related business of Hitachi, Ltd. and established FUJIFILM Healthcare Corporation as a wholly owned subsidiary of FUJIFILM Corporation. Leveraging the Group's technologies and products, Fujifilm has developed one-stop solutions to meet the needs of the medical field. In pursuit of growth through synergy creation, two manufacturing companies in Japan were integrated in October 2021 to consolidate medical device manufacturing functions, resulting in shorter production lead times and reduced costs. To maximize synergies and further accelerate business growth, Fujifilm will reorganize the group companies in Japan involved in business strategy, research and development, and sales and maintenance services, thereby further strengthening the Medical Systems business structure.

Fujifilm will expand its Medical Systems business by developing and providing higher-quality diagnostic solutions, contributing to improving the quality of medical care and maintaining and enhancing people's health.